Literature DB >> 6699635

Isolation of membrane attack complex of complement from myelin membranes treated with serum complement.

B A Silverman, D F Carney, C A Johnston, P Vanguri, M L Shin.   

Abstract

The interaction between complement and myelin membranes and its possible role in myelin damage and in the disposal of damaged myelin in vivo is of interest because activation of complement generates both opsonin(s) and membrane attack complex of complement. In our studies on the role of complement in demyelination, we have shown that isolated myelin activates serum complement in the absence of myelin-specific antibody and that membrane attack complex of complement is the required factor in antibody-mediated demyelination of mouse cerebellar explant cultures. In the present study, we examined whether activation of serum complement by myelin is associated with the formation of membrane attack complex of complement in myelin membranes. Extracts of myelin-associated proteins following incubation of myelin with fresh serum were studied by ultracentrifugation on a sucrose density gradient for detection of C5b-9 neoantigen. The subunit structure of C5b-9 was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, electroblotting, and immunostaining. Results indicate that the macromolecular complex consisting of late-acting complement components, C5-C9, was assembled in the target myelin membranes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699635     DOI: 10.1111/j.1471-4159.1984.tb12706.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  A role for complement in phagocytosis of myelin.

Authors:  B A DeJong; M E Smith
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

Review 2.  Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

Authors:  R W Ledeen; G Chakraborty
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

3.  Immunohistochemical localisation of terminal complement component C9 in experimental allergic encephalomyelitis.

Authors:  C Linington; H Lassmann; B P Morgan; D A Compston
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Degradation of human myelin in vitro by leucocytes from patients with multiple sclerosis.

Authors:  S J Owen; C M Watson; A N Davison
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

Review 5.  Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease.

Authors:  Shlomo Rotshenker
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 6.  Mutations of complement factor I and potential mechanisms of neuroinflammation in acute hemorrhagic leukoencephalitis.

Authors:  Lori Broderick; Chhavi Gandhi; James L Mueller; Christopher D Putnam; Katayoon Shayan; Patricia C Giclas; Karin S Peterson; Seema S Aceves; Robert M Sheets; Bradley M Peterson; Robert O Newbury; Hal M Hoffman; John F Bastian
Journal:  J Clin Immunol       Date:  2012-08-29       Impact factor: 8.317

Review 7.  Progressive multiple sclerosis.

Authors:  Monika Bradl; Hans Lassmann
Journal:  Semin Immunopathol       Date:  2009-11       Impact factor: 9.623

Review 8.  The role of Galectin-3/MAC-2 in the activation of the innate-immune function of phagocytosis in microglia in injury and disease.

Authors:  Shlomo Rotshenker
Journal:  J Mol Neurosci       Date:  2009-02-28       Impact factor: 3.444

9.  Complement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin.

Authors:  Smadar Hadas; Maya Spira; Uwe-Karsten Hanisch; Fanny Reichert; Shlomo Rotshenker
Journal:  J Neuroinflammation       Date:  2012-07-09       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.